Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

622

HTML

5848

Figures (1-4)

147

Tables (1-1)

134

Sum=6751

Publishing Process of This Article

Item

Count

Browse

1059

Download

998

Sum=2057

Feb 21, 2013 (publication date) through Jul 5, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Feb 21, 2013; 19(7): 1104-1110
Published online Feb 21, 2013. doi: 10.3748/wjg.v19.i7.1104

Full Size Figure Download Figure

Figure 1 Study design and flow algorithm of patient selection. G-CSF: Granulocyte-colony stimulating factor.

Citation: Duan XZ, Liu FF, Tong JJ, Yang HZ, Chen J, Liu XY, Mao YL, Xin SJ, Hu JH. Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure. World J Gastroenterol 2013; 19(7): 1104-1110
URL: https://www.wjgnet.com/1007-9327/full/v19/i7/1104.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i7.1104